Medications such as liraglutide, semaglutide, and dulaglutide are based on human GLP-1 rather than exendin-4
Zepbound is ideal for patients who: Want a more aggressive weight-loss option Struggle with metabolic resistance Have tried other treatments but hit plateaus How Wegovy and Zepbound Compare Similarities Both medications: Are FDA-approved for chronic weight management Are given once weekly Improve metabolic function and insulin sensitivity Reduce appetite and cravings Are appropriate for patients with a BMI over 30, or over 27 with weight-related conditions Both are also considered safe when monitored by a qualified medical provider, which is essential to avoid improper dosing and prevent side effects
By directly killing pathogenic bacteria, fungi, and some viruses, it helps restore a healthier microbial balance
Medchemcomm 1 , 50 (2010)
Yes, GLP-1 medications are now FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related health condition, independent of a diabetes diagnosis
Some other candidates in development with long half-lives include Zealand Pharma/Roches Petrelintide (amylin analog), QL Biopharms ZT-002 (GLP-1 RA), and Amgens MariTide (GLP-1 RA/GIP antagonist)
.png)
